|
KMID : 1148920150490030237
|
|
Nuclear Medicine and Molecular Imaging
2015 Volume.49 No. 3 p.237 ~ p.240
|
|
|
FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
|
|
Quak Elske
Kovacs Iringo
Oyen Wim J. G.
Van Der Graaf Winette T. A.
|
|
|
Abstract
|
|
|
|
The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in detecting viable tumours in patients with metastasised non-seminomatous testicular cancer and residual and new masses post chemotherapy remains to be determined. We describe the case of a 41-year-old patient with metastasised non-seminomatous testicular cancer, with both retroperitoneal and extra-retroperitoneal residual masses post chemotherapy, for whom FDG-PET/CT guided major treatment decisions. FDG-PET/CT correctly identified the locations of viable tumour, as was proved by histology, and successfully guided surgery. In conclusion, in selected cases surveillance of patients with non-seminomatous testicular cancer with FDG-PET/CT can guide major treatment decisions when considering surgery for metastatic disease.
|
|
|
KEYWORD
|
|
|
FDG-PET/CT, Testicular cancer, Teratoma, Germ cell tumour
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|